Genelux (GNLX) Shares Outstanding (Diluted) (2022 - 2026)
Genelux (GNLX) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 680.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 44.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.15 Mn |
| Dec 31, 2025 | 37.18 Mn |
| Sep 30, 2025 | 37.89 Mn |
| Jun 30, 2025 | 37.95 Mn |
| Mar 31, 2025 | 34.93 Mn |
| Dec 31, 2024 | 31.45 Mn |
| Sep 30, 2024 | 34.53 Mn |
| Jun 30, 2024 | 29.69 Mn |
| Mar 31, 2024 | 26.85 Mn |
| Dec 31, 2023 | 24.43 Mn |
| Sep 30, 2023 | 26.21 Mn |
| Jun 30, 2023 | 25.07 Mn |
| Mar 31, 2023 | 19.58 Mn |
| Dec 31, 2022 | 9.12 Mn |
| Sep 30, 2022 | 10.07 Mn |